2025³â 08¿ù 09ÀÏ Åä¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92622°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



Çö´ëÂ÷, Çë°¡¸® ¼ö¿äÀÀ´ä±³Åë ½Ã¹ü»ç¾÷ Âü¿©

¼ÅŬ Ç÷§Æû ±Û·Î¹ú »ç¾÷ È®Àå ±â¹Ý ¸¶·Ã
Çö´ëÂ÷°¡ Çë°¡¸®¿¡¼­ Áö¿ª ±³Åë ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇÑ ¼ö¿äÀÀ´ä±³Åë(Demand Responsive Transport, DRT) ¿î¿µ ½Ã¹ü»ç¾÷¿¡ Âü¿©ÇÑ´Ù. ±¹³» ¼º°øÀûÀÎ ¼ö¿äÀÀ´ä±³Åë ¼­ºñ½º Á¦°ø °æÇèÀ» ¹ÙÅÁÀ¸·Î ±Û·Î¹ú ½ÃÀåÀ¸·Î ¼­ºñ½º È®´ë¸¦ ÃßÁøÇÑ´Ù´Â Á¡¿¡¼­ Àǹ̰¡ ÀÖ´Ù. Çö´ëÀÚµ¿Â÷´Â Áö³­´Þ 31ÀÏ(ÇöÁö½Ã°¢) Çë°¡¸® ±«µÉ·Ú(Gödöllő)½Ã¿¡¼­ ¿­¸° ‘Çë°¡¸® ¼ö¿äÀÀ´ä±³Åë ¼­ºñ½º °³Åë½Ä’¿¡¼­ ÃÖ÷´Ü ¼ö¿äÀÀ´ä±³Åë Ç÷§ÆûÀ» Á¦°øÇϰí, ±Û·Î¹ú »ç¾÷ È®Àå ±â¹ÝÀ» ¸¶·ÃÇÑ´Ù°í 3ÀÏ(ÀÏ) ¹àÇû´Ù. °³Åë½Ä¿¡ µû¶ó 8¿ù 18ÀϺÎÅÍ 10¿ù ...

¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
¾Æ·Î¸¶Å×¶óÇÇ ³ìÀ½µµ¼­ ÇÁ·ÎÁ§Æ® ÁøÇà (2021-01-04)
Åä´ß Åä´ß, ¼ö°íÇÑ ³Ê¿¡°Ô ¼±¹°ÇÑ´ß (2020-12-07)
100¸íÀÇ CEO, Çõ½Å¼ºÀå À±¸® ½Çõ Àç°áÀÇ (2019-04-20)
ģȯ°æ ³ì»öû»ç¡®Á¤ºÎ´ë±¸Áö¹æÇÕµ¿Ã»»ç¡¯°³Ã» (2012-11-02)
Æ®¸®Æ÷µå, µðµõ365·Î ¹ýÀÎ¸í º¯°æ (2018-12-29)
±â¾ÆÂ÷-±¸±Û Ŭ¶ó¿ìµå, AI ±â¹Ý Â÷·® ¸Å´º¾ó ¾Û °³¹ß (2020-06-22)
ÇØ¿Ü°Ç¼³ 1¿ù 60¾ï ºÒ ¼öÁÖ, Àü³âº¸´Ù 61% Áõ°¡ (2015-02-10)
¡®Ãµ»ç¼¶ÀÇ ¾ÆÀ̵顯 À¯Æ©ºê ¼Ûµ¿À±TV¼­ °³ºÀ (2022-02-09)
ÆÄ¿ö¿¡ÀÌµå ÆÛÇà ½ºÅ衤¿ùµåÄÅ ½ºÆä¼È ÆÐŰÁö (2018-06-16)
52½Ã°£ ±Ù¹«Á¦°¡ °¡Á®¿Â ȸÀÇ ¹æ½Ä º¯È­ (2020-03-30)
Lineage Logistics Strengthens European Transport Capability ... (2022-01-12)
¡®¸êÁ¾ À§±â µ¿¹° ±â¾ï ÇÁ·ÎÁ§Æ®¡¯ ÅÒºí¹÷ ÆÝµù (2021-12-15)
SK-»ê¸²Ã», ź¼ÒÁ߸³ Ȱµ¿ °­È­ ¾÷¹«Çù¾à (2021-10-20)
10³âÂ÷ Á÷ÀåÀÎ ÀÌÁ÷Ƚ¼ö ¡®Æò±Õ 4ȸ¡¯ (2019-05-27)
¼¶Áø°­ ÀÚÀü°Å±æ, ÀÚ¿¬Ã¼°¨Çü ¸íǰ±æ·Î (2013-01-15)
»ç³ëÇÇ, ¡®¿øÆÄ¿îµ¥À̼ǵ¥ÀÌ¡¯ Á÷¿ø ºÀ»ç 5³â° ÁøÇà (2019-04-29)
AI·Î ÁøÈ­ÇÏ´Â µðÁöÅÐ ÄÁÅü¾ÅÍ ½Ã´ë·Î (2021-04-07)
Çѱ¹ Àü±âÂ÷¿Í ¹èÅ͸® Á¦Á¶»ç, ¹Ì±¹ ½ÃÀå ÁøÃâ È®Àå (2023-06-09)
½ºÆåÃÊ¿ù ä¿ë ¸ø ¹Ï°Ú´Ù¡¦Æò°¡ ±âÁØ ¸ðÈ£ÇØ (2014-09-04)
½ÅÇÑÄ«µå, º»¾÷°ú ½Å»ç¾÷ÀÇ µ¿¹Ý ¼ºÀå (2023-02-17)
'4¼¼´ë Ä«´Ï¹ß' »çÀü°è¾à ù ³¯ 23,006´ë µ¹ÆÄ (2020-07-29)
¾Æ¹ÙŸ¸Þµå, À½¾Ð°Ý¸®½Ç ÇØ¿Ü µ¶Á¡ÆÇ¸Å±Ç ȹµæ (2020-06-03)
´ëÇѹα¹ Â÷ ÆÐŰÁö µðÀÚÀÎ °ø¸ðÀü (2020-05-06)
´ëÀü¡¤¼¼Á¾ û³â °ü±¤ â¾÷ Ȱ¼ºÈ­ ¾ÆÀ̵ð¾î °ø¸ð (2022-10-28)
Á÷ÀåÀÎ 75% ¿îµ¿ Áß... ÇÑ ´Þ Æò±Õ ¿îµ¿ºñ ¡®8¸¸ 6õ¿ø¡¯ (2016-07-25)
       [ÀÌÀü][1]....[2875][2876][2877][2878][2879][2880][2881][2882][2883]...[3705][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..